The United States, along with the rest of the world, has been pushing forward with full force on developing an effective COVID-19 vaccine. With 7 COVID-19 vaccine prospects in phase-three trials, and 17 in or having completed phase-two trials, [I] the idea of having a COVID-19 vaccine by the end of the year calls attention … Continue reading →

The COVID-19 pandemic is raising concerns about the medical and psychological implications for those with Substance Use Disorders (SUD), in particular, Opioid Use Disorder (OUD). A White House drug policy office analysis indicates an 11.4% increase in overdose fatalities in the first four months of 2020, compared to the same time last year. Non-fatal overdoses have increased by 18.6% in the same time frame. [I] Individual states have … Continue reading →